Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Haber

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 27, 2006
Hepatitis C, liver transplantation, and why we should consider children separatelyBarbara Haber
JAMA|November 14, 2023
Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis After Kidney Transplant-ReplyAjit P Limaye, Barbara Haber
Journal of Integrative Neuroscience|July 22, 2022
Craniofacial reconstructions in children with craniosynostosisPeter Spazzapan, Miha Kocar, Andreja Eberlinc, et al.
International Journal of Rehabilitation Research. Internationale Zeitschrift Fur Rehabilitationsforschung. Revue Internationale De Recherches De Readaptation|June 22, 2023
Twenty years of intrathecal baclofen therapy in Slovenia: a retrospective single-center analysis of complicationsMitja Benedičič, Katja Groleger Sršen, Klemen Grabljevec, et al.
The American Journal of Medicine|October 27, 2012
Internist diagnosis and management of chronic hepatitis B virus infectionBrian J McMahon, Joan Block, Barbara Haber, et al.
Journal of Viral Hepatitis|November 10, 2018
The accuracy of baseline viral load for predicting the efficacy of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1a infection: An integrated analysisLawrence Serfaty, Ira Jacobson, Jürgen Rockstroh, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 31, 2008
Cholestasis: current issues and plan for the futureBarbara Haber, Christina Targa Ferreira, Marion Aw, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 24, 2017
Elbasvir/grazoprevir does not worsen renal function in patients with hepatitis C virus infection and pre-existing renal diseaseK Rajender Reddy, David Roth, Annette Bruchfeld, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 23, 2025
Impact of kidney function on 200 days of antiviral prophylaxis for cytomegalovirus disease in CMV-seronegative recipients of CMV-seropositive donor kidneys Post hoc analysis of a randomized, phase 3 trial of letermovir versus valganciclovir prophylaxisKlemens Budde, Nassim Kamar, Marta Crespo, et al.
Clinical and Experimental Nephrology|April 13, 2024
Letermovir safety and efficacy for cytomegalovirus prophylaxis in adult Japanese kidney transplant recipients: a multicenter, open-label, noncomparative Phase 3 studyHideki Ishida, Norihiko Goto, Ryoichi Imamura, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 27, 2006
Hepatitis C, liver transplantation, and why we should consider children separatelyBarbara Haber
JAMA|November 14, 2023
Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis After Kidney Transplant-ReplyAjit P Limaye, Barbara Haber
Journal of Integrative Neuroscience|July 22, 2022
Craniofacial reconstructions in children with craniosynostosisPeter Spazzapan, Miha Kocar, Andreja Eberlinc, et al.
International Journal of Rehabilitation Research. Internationale Zeitschrift Fur Rehabilitationsforschung. Revue Internationale De Recherches De Readaptation|June 22, 2023
Twenty years of intrathecal baclofen therapy in Slovenia: a retrospective single-center analysis of complicationsMitja Benedičič, Katja Groleger Sršen, Klemen Grabljevec, et al.
The American Journal of Medicine|October 27, 2012
Internist diagnosis and management of chronic hepatitis B virus infectionBrian J McMahon, Joan Block, Barbara Haber, et al.
Journal of Viral Hepatitis|November 10, 2018
The accuracy of baseline viral load for predicting the efficacy of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1a infection: An integrated analysisLawrence Serfaty, Ira Jacobson, Jürgen Rockstroh, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 31, 2008
Cholestasis: current issues and plan for the futureBarbara Haber, Christina Targa Ferreira, Marion Aw, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 24, 2017
Elbasvir/grazoprevir does not worsen renal function in patients with hepatitis C virus infection and pre-existing renal diseaseK Rajender Reddy, David Roth, Annette Bruchfeld, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 23, 2025
Impact of kidney function on 200 days of antiviral prophylaxis for cytomegalovirus disease in CMV-seronegative recipients of CMV-seropositive donor kidneys Post hoc analysis of a randomized, phase 3 trial of letermovir versus valganciclovir prophylaxisKlemens Budde, Nassim Kamar, Marta Crespo, et al.
Clinical and Experimental Nephrology|April 13, 2024
Letermovir safety and efficacy for cytomegalovirus prophylaxis in adult Japanese kidney transplant recipients: a multicenter, open-label, noncomparative Phase 3 studyHideki Ishida, Norihiko Goto, Ryoichi Imamura, et al.
Pageof 4